 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
* C-alpha coords only
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
4 terms
|
 |
|
Biological process
|
immune response
|
3 terms
|
 |
|
Biochemical function
|
protein binding
|
3 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
J Biol Chem
269:12874-12879
(1994)
|
|
PubMed id:
|
|
|
|
|
| |
|
X-ray structure of interleukin-1 receptor antagonist at 2.0-A resolution.
|
|
G.P.Vigers,
P.Caffes,
R.J.Evans,
R.C.Thompson,
S.P.Eisenberg,
B.J.Brandhuber.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Interleukin-1 receptor antagonist (IL-1ra) is a natural competitive antagonist
of IL-1. In order to further elucidate the mechanism by which IL-1ra binds
without activating the IL-1 receptor, we have solved the crystal structure of
IL-1ra at 2.0-A resolution. IL-1ra has the same overall beta-trefoil fold as
IL-1 alpha and IL-1 beta and has a very similar hydrophobic core. However, there
are a number of structural differences between the molecules, including
significant differences at the open end of the beta-barrel, which has been
identified in IL-1 beta as a receptor binding site.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Lingel,
T.M.Weiss,
M.Niebuhr,
B.Pan,
B.A.Appleton,
C.Wiesmann,
J.F.Bazan,
and
W.J.Fairbrother
(2009).
Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors--insight into heterotrimeric IL-1 signaling complexes.
|
| |
Structure, 17,
1398-1410.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.A.Skinner,
R.M.Gibson,
N.J.Rothwell,
E.Pinteaux,
and
J.I.Penny
(2009).
Transport of interleukin-1 across cerebromicrovascular endothelial cells.
|
| |
Br J Pharmacol, 156,
1115-1123.
|
 |
|
|
|
|
 |
S.Krishnan,
and
A.A.Raibekas
(2009).
Multistep aggregation pathway of human interleukin-1 receptor antagonist: kinetic, structural, and morphological characterization.
|
| |
Biophys J, 96,
199-208.
|
 |
|
|
|
|
 |
J.R.Alford,
B.S.Kendrick,
J.F.Carpenter,
and
T.W.Randolph
(2008).
High concentration formulations of recombinant human interleukin-1 receptor antagonist: II. Aggregation kinetics.
|
| |
J Pharm Sci, 97,
3005-3021.
|
 |
|
|
|
|
 |
Z.Q.Wen,
X.Cao,
and
A.Vance
(2008).
Conformation and side chains environments of recombinant human interleukin-1 receptor antagonist (rh-IL-1ra) probed by raman, raman optical activity, and UV-resonance Raman spectroscopy.
|
| |
J Pharm Sci, 97,
2228-2241.
|
 |
|
|
|
|
 |
S.Datta,
and
R.R.Maclean
(2007).
Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence.
|
| |
Neurosci Biobehav Rev, 31,
775-824.
|
 |
|
|
|
|
 |
Z.Q.Wen
(2007).
Raman spectroscopy of protein pharmaceuticals.
|
| |
J Pharm Sci, 96,
2861-2878.
|
 |
|
|
|
|
 |
Y.Zhang,
S.Roy,
L.S.Jones,
S.Krishnan,
B.A.Kerwin,
B.S.Chang,
M.C.Manning,
T.W.Randolph,
and
J.F.Carpenter
(2004).
Mechanism for benzyl alcohol-induced aggregation of recombinant human interleukin-1 receptor antagonist in aqueous solution.
|
| |
J Pharm Sci, 93,
3076-3089.
|
 |
|
|
|
|
 |
S.Bird,
J.Zou,
T.Wang,
B.Munday,
C.Cunningham,
and
C.J.Secombes
(2002).
Evolution of interleukin-1beta.
|
| |
Cytokine Growth Factor Rev, 13,
483-502.
|
 |
|
|
|
|
 |
C.A.Dinarello
(1998).
Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist.
|
| |
Int Rev Immunol, 16,
457-499.
|
 |
|
|
|
|
 |
H.C.Wang,
J.Dopazo,
L.G.de la Fraga,
Y.P.Zhu,
and
J.M.Carazo
(1998).
Self-organizing tree-growing network for the classification of protein sequences.
|
| |
Protein Sci, 7,
2613-2622.
|
 |
|
|
|
|
 |
W.P.Arend,
M.Malyak,
C.J.Guthridge,
and
C.Gabay
(1998).
Interleukin-1 receptor antagonist: role in biology.
|
| |
Annu Rev Immunol, 16,
27-55.
|
 |
|
|
|
|
 |
B.S.Kendrick,
B.S.Chang,
T.Arakawa,
B.Peterson,
T.W.Randolph,
M.C.Manning,
and
J.F.Carpenter
(1997).
Preferential exclusion of sucrose from recombinant interleukin-1 receptor antagonist: role in restricted conformational mobility and compaction of native state.
|
| |
Proc Natl Acad Sci U S A, 94,
11917-11922.
|
 |
|
|
|
|
 |
C.A.Dinarello
(1997).
Interleukin-1.
|
| |
Cytokine Growth Factor Rev, 8,
253-265.
|
 |
|
|
|
|
 |
B.S.Chang,
R.M.Beauvais,
T.Arakawa,
L.O.Narhi,
A.Dong,
D.I.Aparisio,
and
J.F.Carpenter
(1996).
Formation of an active dimer during storage of interleukin-1 receptor antagonist in aqueous solution.
|
| |
Biophys J, 71,
3399-3406.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|